Results 151 to 160 of about 429,046 (176)

Clinical characteristics and changes in serum CXCL10 and CXCL16 levels in patients with severe mycoplasma pneumonia. [PDF]

Medicine (Baltimore)
Zhang Y, Ke J, Wang X, Xia S.
europepmc   +1 more source

Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia

Frontiers in Immunology, 2023
Introduction Mycoplasma pneumoniae pneumonia (MPP) may lead to various significant outcomes, such as necrotizing pneumonia(NP) and refractory MPP (RMPP).
Zhao Deyu, Gu Haiyan
exaly   +2 more sources

Immune response plays a role in Mycoplasma pneumoniae pneumonia

Frontiers in Immunology, 2023
Introduction Mycoplasma pneumoniae (MP) is a major pathogen of community-acquired pneumonia in children. However, the specific pathogenesis of the progression of Mycoplasma pneumoniae pneumonia (MPP) is unclear.
Jiang Xinyi, Zhao Deyu, Gu Haiyan
exaly   +2 more sources

Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management

Journal of Clinical Medicine, 2022
Refractory Mycoplasma pneumoniae pneumonia (RMPP) is a severe state of M. pneumoniae infection that has attracted increasing universal attention in recent years. The pathogenesis of RMPP remains unknown, but the excessive host immune responses as well as
Shumin Huang, Zhimin Chen, Chen Zhimin   +2 more
exaly   +2 more sources

Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020

Emerging Microbes and Infections, 2022
The objective of this paper is to explore the characteristics of Mycoplasma pneumoniae (MP) epidemics in Beijing, China. Patients with acute respiratory tract infection (ARTI) were enrolled from 35 sentinel hospitals in Beijing, 2015–2020.
Maozhong Li
exaly   +2 more sources

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children

Clinical Respiratory Journal, 2023
Thromboembolism is less common in children than in adults, but it is frequently associated with Mycoplasma pneumoniae infection in many cases. This study aimed to investigate the clinical characteristics of pediatric M.
Lanqin Chen
exaly   +2 more sources

Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study

Journal of Clinical Medicine, 2022
Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and the treatment of choice is macrolides. There is an increasing trend in reports of refractory clinical responses despite macrolide treatment due to the ...
Ju-Hee Seo, Jin-Tack Kim, Hyung Young Kim   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Mycoplasma Pneumonia in Children and Adolescents

Pediatrics in review, 2020
1. Catherine Krafft, MD* 2. Cynthia Christy, MD†,‡ 1. *Department of Pediatrics and 2. †Division of Pediatric Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, NY 3.
Catherine A Krafft, C. Christy
semanticscholar   +1 more source

Deep learning for mycoplasma pneumonia discrimination from pneumonias like COVID-19

2020 4th International Symposium on Multidisciplinary Studies and Innovative Technologies (ISMSIT), 2020
Mycoplasma pneumonia is an atypical bacterial pneumonia with dry cough as its most common symptom. It may occur as a coinfection along with the newly discovered COVID19.
Ali Serener, Sertan Serte
semanticscholar   +1 more source